FDA increases estimate of scope-related infections

Food and Drug Administration says the number is closer to 350


The Food and Drug Administration has raised the number of infections linked to improperly cleaned scopes from 142 to about 350, according to an article on the Becker's Hospital Review website.

According to Kaiser Health News, the FDA released new numbers in response to an inquiry from U.S. Rep. Ted Lieu from California and the House Committee on Oversight and Government Reform. 

These infections occurred from Jan. 1, 2010, to Oct. 31, 2015, in 30 facilities in the U.S. and 11 facilities abroad.

Since discovering the link between these scopes and the spread of antibiotic-resistant bacteria, hospitals have changed their reprocessing protocols and a major duodenoscope manufacturer issued a voluntary recall of one type of such scopes for modifications.

Read the article.

 

 



April 27, 2016


Topic Area: Safety


Recent Posts

17 Million Patient Records Stolen in PIH Health Ransomware Attack

A ransomware attack halted operations across three of PIH’s hospitals.


Holidays are Prime Times for Healthcare Cyberattacks

A study found that 86 percent of organizations that experienced ransomware attacks were targeted on a holiday or weekend.


Hartford Healthcare Forms Partnership to Open Health Equity Clinic

The new clinic will open in January 2025.


UCHealth Reveals Plans for Memorial Hospital North Expansion

Construction on the patient tower is slated for 2026 with a projected opening to patients in 2029.


What Are 'Hospi-tels'?

Hospitals and hotels are partnering to better cater to patients and families.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.